Zostavax Sales Data
| Rank 87 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Zostavax U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 87 ( 12) |
$202,240 | 15.17% | 182 | 20.53% |
| Q3 2013 | 99 ( ) |
$175,606 | n/a | 151 | n/a |
| Q4 2012 | 70 (14) |
$222,633 | 14.39% | 223 | 10.95% |
| Q3 2012 | 84 () |
$194,633 | n/a | 201 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
